Abstract
Children born with congenital heart disease may outgrow materials used to palliate their heart defects. Application of evolving bioresorbable technologies to these children may assist in providing minimally invasive options that lead to restoration of vascular function, arterial remodeling and vessel growth. The availability of this technology for children may be even more vital than its use in adults as early reversal of vessel stenosis in children may have a profound impact on lifetime vessel development, and the disappearance of the scaffold over time ensures that somatic development should not lead to stent outgrowth. This review evaluates the progress of bioresorbable scaffold development as applied to children with congenital heart disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
